Tackling Grand Challenges with Competition Law: Lessons from the Pandemic
Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
Standard
Tackling Grand Challenges with Competition Law : Lessons from the Pandemic. / Lianos, Ioannis; Minssen, Timo; Kollmar, Christy Lynne.
EU Competition Law and Pharmaceuticals . ed. / Wolf Sauter; Marcel Canoy; Jotte Mulder. Edward Elgar Publishing, 2022. p. 281-297 (New Horizons in Competition Law and Economics series).Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - CHAP
T1 - Tackling Grand Challenges with Competition Law
T2 - Lessons from the Pandemic
AU - Lianos, Ioannis
AU - Minssen, Timo
AU - Kollmar, Christy Lynne
PY - 2022
Y1 - 2022
N2 - All across the globe antitrust authorities responded quickly, determined to tackle the worst impacts of the COVID-19 outbreak. While regulators and courts can apply competition and antitrust rules both as enforcing “swords” to achieve public health goals and “enabling” shields to promote specific collaborations, it appears that the “enabling collaborations” function has been particularly important to rapidly facilitate much needed pandemic responses. This chapter describes these developments from a past, present and future perspective. Specifically, it analyses (1) the interaction between competition law and public health, (2) the immediate response of antitrust authorities during the crisis, and (3) new approaches and solutions models. Special emphasis will be placed on the question of whether current pandemic responses could provide competition authorities a future blueprint and toolkit for action and a new role in the public ecosystem to implement needed sustainable development objectives.
AB - All across the globe antitrust authorities responded quickly, determined to tackle the worst impacts of the COVID-19 outbreak. While regulators and courts can apply competition and antitrust rules both as enforcing “swords” to achieve public health goals and “enabling” shields to promote specific collaborations, it appears that the “enabling collaborations” function has been particularly important to rapidly facilitate much needed pandemic responses. This chapter describes these developments from a past, present and future perspective. Specifically, it analyses (1) the interaction between competition law and public health, (2) the immediate response of antitrust authorities during the crisis, and (3) new approaches and solutions models. Special emphasis will be placed on the question of whether current pandemic responses could provide competition authorities a future blueprint and toolkit for action and a new role in the public ecosystem to implement needed sustainable development objectives.
KW - Faculty of Law
KW - competition law
KW - sustainable pharma
KW - grand challenges
KW - public health
KW - coopetition
KW - collaboration
KW - regulatory sandboxes
UR - https://ssrn.com/abstract=3985344
U2 - 10.2139/ssrn.3985344
DO - 10.2139/ssrn.3985344
M3 - Book chapter
SN - 9781802204407
T3 - New Horizons in Competition Law and Economics series
SP - 281
EP - 297
BT - EU Competition Law and Pharmaceuticals
A2 - Sauter, Wolf
A2 - Canoy, Marcel
A2 - Mulder, Jotte
PB - Edward Elgar Publishing
ER -
ID: 284491361